Pamiron, Jacqueline .
HRN: 22-66-34 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 500MG (TAB)
05/27/2023
06/02/2023
PO
500mg
BID
Post Episiorrhaphy
Checking Final Appropriateness
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
06/02/2023
IV
1.5gm
Q8
Elevated WBC
Checking Final Appropriateness